Reversal of recurrent thrombocytopenia due to abciximab.
作者信息
Sharma Vibhavasu, Mascarenhas Dan
机构信息
Easton Hospital, 175 South 21st Street, Easton, PA,18042, USA.
出版信息
J Invasive Cardiol. 2004 Sep;16(9):537-8.
PMID:15353816
Abstract
摘要
相似文献
1
Reversal of recurrent thrombocytopenia due to abciximab.
J Invasive Cardiol. 2004 Sep;16(9):537-8.
2
Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention.
Am J Cardiol. 2004 Feb 15;93(4):453-5. doi: 10.1016/j.amjcard.2003.10.041.
3
Readministration of abciximab in percutaneous coronary intervention.
J Invasive Cardiol. 1999 Apr;11(4):251-8.
4
A case of pseudothrombocytopenia after infusion of abciximab in vivo and anticoagulant-independent platelet clumping after rechallenge with abciximab in vitro.
Wien Klin Wochenschr. 2000 Feb 11;112(3):138-41.
5
Thrombocytopenia and glycoprotein IIb-IIIa receptor antagonists.
Lancet. 1999 Apr 3;353(9159):1185. doi: 10.1016/s0140-6736(05)74405-6.
6
Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.
J Invasive Cardiol. 2001 Jan;13(1):56-8.
7
Delayed immune-mediated thrombocytopenia after re-exposure to abciximab therapy.
Can J Cardiol. 2011 Nov-Dec;27(6):869.e13-4. doi: 10.1016/j.cjca.2011.05.011. Epub 2011 Sep 1.
8
Thrombocytopenia associated with c7E3 Fab (abciximab).
Ann Hematol. 2002 Feb;81(2):76-9. doi: 10.1007/s00277-001-0414-7. Epub 2002 Jan 18.
9
Acute profound thrombocytopenia following abciximab therapy.
Ann Pharmacother. 2000 Jul-Aug;34(7-8):924-30. doi: 10.1345/aph.19299.
10
The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.
Thromb Haemost. 1999 Nov;82(5):1560-1.
Zotero 插件